Clinical trials
Gastric clinical trials
Below are recruiting gastric clinical trials, each written for real people, not researchers. We’re tracking 854 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06059495RecruitingPhase 2
Watch-and-wait with dostarlimab for MSI-H stomach cancer
This trial is testing a watch-and-wait approach using the immunotherapy drug dostarlimab for people with a specific type of stomach cancer (dMMR/MSI-H) that hasn't spread. The goal is to see if the drug can eliminate the need for surgery or other treatments.
LilleAges 18–75 - NCT07462923RecruitingPhase 1
A study of HS-20093 for advanced stomach or gastroesophageal cancer
This trial tests a new drug, HS-20093, in people with advanced stomach or gastroesophageal junction cancer that has not responded to other treatments. The goal is to see if it can help shrink or slow the growth of the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06711471RecruitingPhase 2
Combination therapy for advanced stomach cancer after prior treatments
This trial tests a combination of three drugs — trifluridine/tipiracil (a chemotherapy pill), bevacizumab (avastin, a targeted therapy), and camrelizumab (an immunotherapy) — as a later treatment option for people with advanced stomach cancer who have already tried other therapies. It may help patients whose cancer has not responded to previous treatments.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06736314Recruiting
Removable clip treatment for stomach varices bleeding
This trial tests a removable titanium clip to stop bleeding from enlarged veins in the stomach caused by cirrhosis. It may be an option for patients who are stable enough for this procedure.
Nanjing, JiangsuAges 18–75 - NCT04982276RecruitingPhase 1/Phase 2
Test new cancer drugs for advanced stomach or esophagus cancer
This Phase 1/2 study tests the safety and effectiveness of two investigational drugs (AK109 and AK104) in people with advanced stomach (or lower esophagus/GEJ) cancer. It’s for cases where the cancer did not respond to first-line treatment that included anti–PD-1/PD-L1 therapy plus chemotherapy.
BeijingAges 18–75 - NCT05753306RecruitingPhase 2
Robot surgery plus heated chemo for limited spread stomach cancer
This study tests a “robot-assisted” surgery to remove stomach cancer in the belly lining (peritoneum) along with heated chemotherapy placed inside the abdomen. It’s for people whose cancer has spread only in the peritoneum, aiming to control disease when there’s a good chance of removing it all.
Rochester, MinnesotaAges 18–80 - NCT06075199Recruiting
Study of stomach lining changes for cancer risk
This study follows people with intestinal metaplasia (a change in the stomach lining) over time to better understand who might develop stomach cancer. It does not test a new treatment but aims to improve prediction and prevention.
SeoulAges 18 years+ - NCT04891016RecruitingPhase 2
Immunotherapy with chemotherapy for locally advanced stomach cancer
This trial studies toripalimab (an immune system medicine) plus FLOT chemotherapy in people with stomach cancer that has grown locally but hasn’t spread to distant organs. It aims to improve control of the cancer and help more people have their tumors fully treated.
Zhengzhou, HenanAges 18–70 - NCT06422793Recruiting
Does a stomach tube reduce nausea after jaw surgery?
This study tests whether using a thin tube through the nose into the stomach during jaw surgery helps reduce nausea and vomiting after the operation. It's for people having certain types of jaw surgery to correct bite or facial problems.
Halifax, Nova ScotiaAges 16 years+ - NCT07127822RecruitingPhase 2
Testing a new immunotherapy combo for MSI-H gastric cancer
This trial tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) for people with advanced gastric cancer that has a specific DNA repair problem (MSI-H/dMMR). It is for those who have not yet had any treatment for their advanced cancer.
Shijiazhuang, HebeiAges 18 years+ - NCT07517419Enrolling by invitationPhase 2
Pressurized chemotherapy for gastric cancer spread in abdomen
This trial tests a specialized chemotherapy delivery method called PIPAC—where chemotherapy is sprayed directly into the abdomen under pressure—for patients with gastric cancer that has spread to the abdominal lining. The goal is to deliver stronger doses of chemotherapy directly to where the cancer is, potentially helping patients who aren't candidates for major surgery.
Hong KongAges 18–80 - NCT05640830RecruitingPhase 1/Phase 2
Trastuzumab, bevacizumab, and paclitaxel for HER2-positive stomach cancer
This trial tests a combination of anti-cancer medicines for HER2-positive advanced stomach cancer that has already been treated once. It may help shrink tumors and slow the disease by targeting HER2 and blocking tumor blood supply.
SeoulAges Any age - NCT07043400RecruitingPhase 3
Study comparing two ways to give tislelizumab plus chemo for stomach cancer
This trial compares a shot under the skin versus an IV infusion of tislelizumab, given along with chemotherapy, for people with advanced stomach or gastroesophageal junction cancer that has not been treated before. The goal is to see if the shot works as well as the IV and may be more convenient.
Chandler, ArizonaAges 18 years+ - NCT06123494RecruitingPhase 3
A trial of SHR-A1811 for HER2-positive gastric cancer
This trial tests a new drug, SHR-A1811, for people with HER2-positive stomach or gastroesophageal junction cancer that has worsened after initial treatment. It aims to see if this drug can help when standard anti-HER2 therapy stops working.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07483567RecruitingPhase 2
Combination treatment before and after stomach cancer surgery
This trial tests a combination of experimental drugs (IBI343, Sintilimab, and chemotherapy) before and after surgery for a specific type of stomach cancer that is CLDN18.2 positive. The goal is to see if this treatment shrinks the tumor and helps prevent the cancer from coming back.
Beijing, Beijing MunicipalityAges 18–75 - NCT07464756RecruitingPhase 2
Study of SHR-1701 and apatinib with chemo before stomach cancer surgery
This trial tests whether adding SHR-1701 (an immunotherapy) with or without apatinib (a targeted therapy) to standard chemotherapy before surgery can help treat gastric cancer. It is for people with stomach or gastroesophageal junction cancer that has spread to nearby lymph nodes but is still removable.
Nanjing, JiangsuAges 18 years+ - NCT06597227Recruiting
Partial vs total stomach removal for upper stomach cancer after chemo
This trial compares two types of surgery for upper stomach cancer after chemotherapy or radiation. It aims to see if removing only part of the stomach (proximal gastrectomy) works as well as removing the whole stomach (total gastrectomy) to help you recover better.
Wuhan, HubeiAges 18–75 - NCT06814080Recruiting
Stomach Content Study for GLP-1 Users Before Surgery
This study looks at whether a common diabetes medication (GLP-1) affects how much food stays in your stomach before surgery. It aims to make anesthesia safer by understanding stomach content.
Little Rock, ArkansasAges 18 years+ - NCT07451470Recruiting
Comparing two airway devices for stomach air in children during short surgeries
This trial compares two devices used to help children breathe during surgery (LarySeal Pro and Ambu AuraGain). It measures how much air gets into the stomach, which can cause discomfort. It is for children aged 6–12 having short elective surgeries (1 hour or less).
Cairo, Cairo GovernorateAges 6–10 - NCT06610760RecruitingPhase 4
Ursodeoxycholic acid for stomach precancer reversal
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
Pingdingshan, HenanAges 18–75 - NCT07436013Recruiting
Comparing two types of weight-loss revision surgery after sleeve gastrectomy
This trial compares two surgical options for people who have regained weight or didn't lose enough after a sleeve gastrectomy. It tests whether adding a ring to the standard revision surgery helps with long-term weight loss.
Alexandria, Alexandria GovernorateAges 18–65 - NCT07407530Recruiting
Sipping fluids before planned c-section
This trial tests whether drinking small amounts of clear fluids up until surgery is safe for women having a planned c-section. It uses an ultrasound to check the stomach before the procedure.
Dublin, Ireland/County DublinAges 18 years+ - NCT06590454RecruitingPhase 2
Reversing stomach lining changes to lower cancer risk
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
Durham, North CarolinaAges 18 years+ - NCT07398222Recruiting
Stomach contents in tirzepatide users and fasting volunteers
This study uses an ultrasound to look at the stomach contents of people who are taking tirzepatide compared to those who are not. It will help doctors understand how this medication affects stomach emptying during fasting.
São Paulo, São PauloAges 18 years+
Hear when a new Gastric trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric?
- Yes. Clin2 currently lists 854 recruiting gastric studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.